Dysregulation of the Wnt/β-catenin signaling pathway via Rnf146 upregulation in a VPA-induced mouse model of autism spectrum disorder

참고문헌 (91)

1. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders: DSM-5™" (2013), American Psychiatric Publishing, Inc.
2. Fischbach, G. D., "The Simons simplex collection : a resource for identification of autism genetic risk factors", Neuron, 68, pp.192~195 (2010)
3. Ehninger, D., "Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice", Mol. Psychiatry, 17, pp.62~70 (2012)
4. Reed, M. D., "IL-17a promotes sociability in mouse models of neurodevelopmental disorders", Nature, 577, pp.249~253 (2020)
5. Perucca, E., "Pharmacological and therapeutic properties of valproate : a summary after 35 years of clinical experience", CNS Drugs, 16, pp.695~714 (2002)
6. Vorhees, C. V., "Teratogenicity and developmental toxicity of valproic acid in rats", Teratology, 35, pp.195~202 (1987)
7. Bromley, R. L., "Autism spectrum disorders following in utero exposure to antiepileptic drugs", Neurology, 71, pp.1923~1924 (2008)
8. Rasalam, A. D., "Characteristics of fetal anticonvulsant syndrome associated autistic disorder", Dev. Med. Child Neurol, 47, pp.551~555 (2005)
9. Go, H. S., "Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta", beta-catenin pathway, 2012, pp.63, 1028~1041
10. Kim, K. C., "The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats", Toxicol. Lett, 201, pp.137~142 (2011)
11. Darine Froy N. Mabunga, "Exploring the Validity of Valproic Acid Animal Model of Autism", Experimental Neurobiology, 24(4), pp.285~300 (2015), 한국뇌신경과학회
12. Roullet, F. I., "In utero exposure to valproic acid and autism–a current review of clinical and animal studies", Neurotoxicol. Teratol, 36, pp.47~56 (2013)
13. Chomiak, T., "What we have learned about autism spectrum disorder from valproic acid", Pathol. Res. Int, 2013, pp.712758~ (2013)
14. Nicolini, C., "The valproic acid-induced rodent model of autism", Exp. Neurol, 299, pp.217~227 (2018)
15. Schneider, T., "Behavioral alterations in rats prenatally exposed to valproic acid : animal model of autism", Neuropsychopharmacology, 30, pp.80~89 (2005)
16. Markram, K., "Abnormal fear conditioning and amygdala processing in an animal model of autism", Neuropsychopharmacology, 33, pp.901~912 (2008)
17. Wang, R., "Aberrant development and synaptic transmission of cerebellar cortex in a VPA induced mouse autism model", Front. Cell. Neurosci, 12 (2018)
18. Yamaguchi, H., "Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice", Behav. Brain Res, 333, pp.67~73 (2017)
19. Lazaro, M. T., "Reduced prefrontal synaptic connectivity and disturbed oscillatory population dynamics in the CNTNAP2 model of autism", Cell Rep, 27, pp.2567~2578 (2019)
20. Qiu, S., "Circuit-specific intracortical hyperconnectivity in mice with deletion of the autism-associated met receptor tyrosine kinase", J. Neurosci, 31, pp.5855~ (2011)
21. Gobbi, G., "Sodium-and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex", Psychopharmacology, 185, pp.255~262 (2006)
22. Kalkman, H. O., "A review of the evidence for the canonical Wnt pathway in autism spectrum disorders", Mol. Autism, 3, pp.10~ (2012)
23. Krumm, N., "A de novo convergence of autism genetics and molecular neuroscience", Trends Neurosci, 37, pp.95~105 (2014)
24. Kwan, V., "Wnt signaling networks in autism spectrum disorder and intellectual disability", J. Neurodev. Disord, 8, pp.45~ (2016)
25. Qin, L., "Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats", Mol. Cell. Neurosci, 75, pp.27~35 (2016)
26. Zhang, Y., "Downregulating the canonical Wnt", beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress, 2012, pp.37, 1409~1419
27. An, J. Y., "Towards a molecular characterization of autism spectrum disorders : an exome sequencing and systems approach", Transl. Psychiatry, 4, pp.e394~ (2014)
28. Jang, W. E., "Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis", Mol. Psychiatry, 28, pp.810~821 (2023)
29. Velmeshev, D., "Single-cell genomics identifies cell type-specific molecular changes in autism", Science, 364, pp.685~689 (2019)
30. Aebersold, R., "Mass-spectrometric exploration of proteome structure and function", Nature, 537, pp.347~355 (2016)
31. Kim, M. S., "A draft map of the human proteome", Nature, 509, pp.575~581 (2014)
32. Sebat, J., "Strong association of De Novo copy number mutations with autism", Science, 316, pp.445~449 (2007)
33. Kojic, M., "Elp2 mutations perturb the epitranscriptome and lead to a complex neurodevelopmental phenotype", Nat. Commun, 12, pp.2678~ (2021)
34. Thacker, S., "Transcriptome-(phospho)proteome characterization of brain of a germline model of cytoplasmic-predominant Pten expression with autismlike phenotypes", Npj. Genom. Med, 6, pp.42~ (2021)
35. Courchesne, E., "Neuron number and size in prefrontal cortex of children with autism", JAMA, 306, pp.2001~2010 (2011)
36. Rinaldi, T., "Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic acid animal model of autism", Front. Neural Circuit, 2 (2008)
37. Bicks, L. K., "Prefrontal cortex and social cognition in mouse and man", Front. Psychol, 6, pp.1805~ (2015)
38. Kim, J. -W., "Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism", Neuropsychopharmacology, 44, pp.314~323 (2019)
39. Park Ji-Hwan, "Disruption of nucleocytoplasmic trafficking as a cellular senescence driver", Experimental and Molecular Medicine, 53, pp.1~17 (2021), 생화학분자생물학회[DOI]
40. Cox, J., "MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification", Nat. Biotechnol, 26, pp.1367~1372 (2008)
41. Jassal, B., "The reactome pathway knowledgebase", Nucleic Acids Res, 48, pp.D498~D503 (2020)
42. Kuleshov, M. V., "Enrichr : a comprehensive gene set enrichment analysis web server 2016 update", Nucleic Acids Res, 44, pp.W90~W97 (2016)
43. Kechin, A., "cutPrimers : a new tool for accurate cutting of primers from reads of targeted next generation sequencing", J. Comput. Biol, 24, pp.1138~1143 (2017)
44. Patro, R., "Salmon provides fast and bias-aware quantification of transcript expression", Nat. Methods, 14, pp.417~419 (2017)
45. Ryu, H. -H., "Excitatory neuron-specific SHP2-ERK signaling network regulates synaptic plasticity and memory", Sci. Signal, 12, pp.eaau5755~ (2019)
46. Park, G., "Social isolation impairs the prefrontal-nucleus accumbens circuit subserving social recognition in mice", Cell Rep, 35 (2021)
47. Yang, M., "Automated three-chambered social approach task for mice", Curr. Protoc. Neurosci, pp.8~26 (2011)
48. Zeisel, A., "Molecular architecture of the mouse nervous system", Cell, 174, pp.999~1014 (2018)
49. Nowakowski, T. J., "Spatiotemporal gene expression trajectories reveal developmental hierarchies of the human cortex", Science, 358, pp.1318~1323 (2017)
50. Parikshak, N. N., "Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism", Nature, 540, pp.423~427 (2016)
51. Fu, J. M., "Rare coding variation provides insight into the genetic architecture and phenotypic context of autism", Nat. Genet, 54, pp.1320~1331 (2022)
52. Kaplanis, J., "Evidence for 28 genetic disorders discovered by combining healthcare and research data", Nature, 586, pp.757~762 (2020)
53. Heyne, H. O., "De novo variants in neurodevelopmental disorders with epilepsy", Nat. Genet, 50, pp.1048~1053 (2018)
54. Singh, T., "Rare coding variants in ten genes confer substantial risk for schizophrenia", Nature, 604, pp.509~516 (2022)
55. Li, J., "CBP", p300 are bimodal regulators of Wnt signaling, 2007, pp.26, 2284~2294
56. Ciani, L., "Wnt signalling tunes neurotransmitter release by directly targeting Synaptotagmin-1", Nat. Commun, 6, pp.8302~ (2015)
57. Nielsen, C. P., "USP9X deubiquitylates DVL2 to regulate WNT pathway specification", Cell. Rep, 28, pp.1074~1089 (2019)
58. Zhang, Y., "RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling", Nat. Cell Biol, 13, pp.623~629 (2011)
59. Lee, E., "The roles of APC and axin derived from experimental and theoretical analysis of the Wnt pathway", PLoS Biol, 1, pp.e10~ (2003)
60. Gao, W., "The role of glypican-3 in regulating Wnt in hepatocellular carcinomas", Cancer Rep, 1, pp.14~19 (2011)
61. Koopmans, F., "SynGO : an evidence-based, expert-curated knowledge base for the synapse", Neuron, 103, pp.217~234 (2019)
62. Ahmad-Annuar, A., "Signaling across the synapse : a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release", J. Cell Biol, 174, pp.127~139 (2006)
63. Ravindranath, A., "Wnt–β-catenin–Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer", Br. J. Cancer, 105, pp.542~551 (2011)
64. Cheon, S., "The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK", Proc. Natl Acad. Sci. USA, 116, pp.3662~3667 (2019)
65. Basel-Vanagaite, L., "Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome", Am. J. Hum. Genet, 91, pp.998~1010 (2012)
66. Brumback, A. C., "Identifying specific prefrontal neurons that contribute to autism-associated abnormalities in physiology and social behavior", Mol. Psychiatry, 23, pp.2078~2089 (2018)
67. Rinaldi, T., "Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid", Proc. Natl Acad. Sci, 104, pp.13501~13506 (2007)
68. Yang, Y., "RNF146 inhibits excessive autophagy by modulating the Wnt-β-catenin pathway in glutamate excitotoxicity injury", Front. Cell. Neurosci, 11 (2017)
69. Kim, H., "Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson’s disease models", Oncotarget, 8 (2017)
70. Shen, J., "The E3 ubiquitin ligase RNF146 promotes colorectal cancer by activating the Wnt", β-catenin pathway via ubiquitination of Axin1, 2018, pp.503, 991~997
71. Abrahams, B. S., "SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)", Mol. Autism, 4, pp.36~ (2013)
72. Ruzzo, E. K., "Inherited and De Novo genetic risk for autism impacts shared networks", Cell, 178, pp.850~866 (2019)
73. Martin, P. M., "DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt", β-catenin signaling, 2018, pp.23, 467~475
74. Zhang, Y., "Genetic evidence of gender difference in autism spectrum disorder supports the female-protective effect", Transl. Psychiatry, 10, pp.4~ (2020)
75. Freese, J. L., "Wnt signaling in development and disease", Neurobiol. Dis, 38, pp.148~153 (2010)
76. Huang, H., "Wnt", β-catenin signaling : new(and old)players and new insights, 2008, pp.20, 119~125
77. Mulligan, K. A., "Wnt signaling in vertebrate neural development and function", J. Neuroimmune Pharmacol, 7, pp.774~787 (2012)
78. Brien, W. T., "Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium", J. Neurosci, 24, pp.6791~ (2004)
79. Latapy, C., "Selective deletion of forebrain glycogen synthase kinase 3β reveals a central role in serotonin-sensitive anxiety and social behaviour", Philos. Trans. R. Soc. Lond. B : Biol. Sci, 367, pp.2460~2474 (2012)
80. Fang, W. -Q., "Overproduction of upper-layer neurons in the neocortex leads to autism-like features in mice", Cell Rep, 9, pp.1635~1643 (2014)
81. Cui, K., "Neurodevelopmental impairment induced by prenatal valproic acid exposure shown with the human cortical organoid-on-a-chip model", Microsyst. Nanoeng, 6, pp.49~ (2020)
82. Peukert, D., "Lhx2 and Lhx9 determine neuronal differentiation and compartition in the caudal forebrain by regulating Wnt signaling", PLoS Biol, 9, pp.e1001218~ (2011)
83. Mines, M. A., "GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism", PLoS ONE, 5, pp.e9706~ (2010)
84. Choi, C. H., "Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment", Brain Res, 1380, pp.106~119 (2011)
85. Arredondo, S. B., "Role of Wnt signaling in adult hippocampal neurogenesis in health and disease", Front. Cell Dev. Biol, 8, pp.860~ (2020)
86. McLeod, F., "Wnt proteins as modulators of synaptic plasticity", Curr. Opin. Neurobiol, 53, pp.90~95 (2018)
87. Rosso, S., "WNT signaling in neuronal maturation and synaptogenesis", Front. Cell. Neurosci, 7 (2013)
88. Okuda, T., "β-Catenin regulates excitatory postsynaptic strength at hippocampal synapses", Proc. Natl Acad. Sci, 104, pp.13479~13484 (2007)
89. Sun, M., "Presynaptic contributions of chordin to hippocampal plasticity and spatial learning", J. Neurosci, 27, pp.7740~ (2007)
90. Kim, K. C., "Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder", J. Neurochem, 124, pp.832~843 (2013)
91. Kataoka, S., "Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid", Int. J. Neuropsychopharmacol, 16, pp.91~103 (2013)

관련 논문AI추천